Research / ALSN / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-25-257624 General Corporate
Debt relative to revenue 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
347.76% · OPTIONAL · VALID
Capex intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.35% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
32.90% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
-15.90% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
47.76% · OPTIONAL · VALID
Gross margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
47.47% · CORE · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
29.44% · CORE · VALID
R&D intensity 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.20% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.87% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 0/9 normalized Level 3 Mar 31, 2022 0/9 normalized Level 3 Jun 30, 2022 8/9 normalized Level 3 Sep 30, 2022 8/9 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 296.31%
Current 347.76%
Delta 51.45% Capex Intensity Increased
Previous 3.81%
Current 6.35%
Delta 2.54% Cash Generation Increased
Previous 22.60%
Current 32.90%
Delta 10.30% Growth Decreased
Previous -0.25%
Current -15.90%
Delta -15.65% Inventory Pressure Increased
Previous 41.89%
Current 47.76%
Delta 5.87% Margin Decreased
Previous 49.39%
Current 47.47%
Delta -1.91% Profitability Decreased
Previous 31.45%
Current 29.44%
Delta -2.01% R And D Intensity Increased
Previous 5.41%
Current 6.20%
Delta 0.80% Sbc Intensity Decreased
Previous 0.98%
Current 0.87%
Delta -0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.